Next Article in Journal
Update on the Non-Pharmacological Management of Stroke Prevention in Patients with Atrial Fibrillation
Next Article in Special Issue
The Role of Diffusion-Weighted Magnetic Resonance Imaging in the Differentiation of Head and Neck Masses
Previous Article in Journal
Experience of Nurses in Hemodialysis Care: A Phenomenological Study
Previous Article in Special Issue
Acute Encephalitis in an Adult with Diffuse Large B-Cell Lymphoma with Secondary Involvement of the Central Nervous System: Infectious or Non-Infectious Etiology?
Article Menu
Issue 2 (February) cover image

Export Article

Open AccessArticle
J. Clin. Med. 2018, 7(2), 31; https://doi.org/10.3390/jcm7020031

Canaloplasty in Corticosteroid-Induced Glaucoma. Preliminary Results

1
Department of Ophthalmology, “Città di Udine” Health Center, Viale Venezia, 410, 33100 Udine, Italy
2
Department of Ophthalmology, “Azienda Ospedaliero-Universitaria” “Santa Maria della Misericordia” Hospital of Udine, P.le S. Maria della Misericordia, 15, 33100 Udine, Italy
*
Author to whom correspondence should be addressed.
Received: 11 December 2017 / Revised: 15 January 2018 / Accepted: 7 February 2018 / Published: 11 February 2018
Full-Text   |   PDF [510 KB, uploaded 12 February 2018]   |  

Abstract

Purpose: to present the mid-term results of canaloplasty in a small cohort of corticosteroid glaucoma patients. Material and Methods: Nine eyes from seven patients with various types of corticosteroid glaucoma in maximum medical therapy underwent canaloplasty. Patients underwent complete ophthalmic examination every six months. Success was defined as: post-operative intraocular pressure (IOP) ≤ 21 mmHg and ≤ 16 mmHg without (“complete success”), and with/without medical treatment (“qualified success”). The IOP reduction had to be ≥ 20. The number of medications before and after surgery was considered. The follow-up mean period was 32.7 ± 20.8 months (range 14–72 months). Results: The pre-operative mean IOP was 30.7 ± 7.2 mmHg (range: 24–45). The mean IOP at 6 and 12-month follow-up was 13.1 ± 2.6 mmHg, and 13.7 ± 1.9 mmHg, respectively. Qualified and complete success at 6 and 12 months was 100% for both of the two definitions. The number of medications used preoperatively and at the 12-month follow-up was 4.3 ± 0.7, and 0.2 ± 1.0, respectively. No serious complication was observed. Conclusions: The mid-term results of canaloplasty in patients with corticosteroid-induced glaucoma appear to be very promising. Canaloplasty should be considered as a possible alternative to filtering surgery in this form of glaucoma, when medical therapy is not sufficient to maintain the IOP within reasonable limits. View Full-Text
Keywords: canaloplasty; non-perforating surgical procedures; corticosteroid-induced glaucoma; Schlemm’s canal canaloplasty; non-perforating surgical procedures; corticosteroid-induced glaucoma; Schlemm’s canal
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Brusini, P.; Tosoni, C.; Zeppieri, M. Canaloplasty in Corticosteroid-Induced Glaucoma. Preliminary Results. J. Clin. Med. 2018, 7, 31.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top